Skip to main content

Ann Hanham

Ann Hanham has been appointed the chair of HTG Molecular Diagnostics' board. Hanham has more than 15 years of experience in the life science investment sector as a founding member and managing partner of BAR Capital Management. Before that, she was a managing director and general partner of Burrill & Co. 

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.